These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. Phyo AP; Jittamala P; Nosten FH; Pukrittayakamee S; Imwong M; White NJ; Duparc S; Macintyre F; Baker M; Möhrle JJ Lancet Infect Dis; 2016 Jan; 16(1):61-69. PubMed ID: 26448141 [TBL] [Abstract][Full Text] [Related]
6. A Single-Dose Combination Study with the Experimental Antimalarials Artefenomel and DSM265 To Determine Safety and Antimalarial Activity against Blood-Stage Plasmodium falciparum in Healthy Volunteers. McCarthy JS; Rückle T; Elliott SL; Ballard E; Collins KA; Marquart L; Griffin P; Chalon S; Möhrle JJ Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685476 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria. Adoke Y; Zoleko-Manego R; Ouoba S; Tiono AB; Kaguthi G; Bonzela JE; Duong TT; Nahum A; Bouyou-Akotet M; Ogutu B; Ouedraogo A; Macintyre F; Jessel A; Laurijssens B; Cherkaoui-Rbati MH; Cantalloube C; Marrast AC; Bejuit R; White D; Wells TNC; Wartha F; Leroy D; Kibuuka A; Mombo-Ngoma G; Ouattara D; Mugenya I; Phuc BQ; Bohissou F; Mawili-Mboumba DP; Olewe F; Soulama I; Tinto H; Malar J; 2021 May; 20(1):222. PubMed ID: 34011358 [TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria. Macintyre F; Adoke Y; Tiono AB; Duong TT; Mombo-Ngoma G; Bouyou-Akotet M; Tinto H; Bassat Q; Issifou S; Adamy M; Demarest H; Duparc S; Leroy D; Laurijssens BE; Biguenet S; Kibuuka A; Tshefu AK; Smith M; Foster C; Leipoldt I; Kremsner PG; Phuc BQ; Ouedraogo A; Ramharter M; BMC Med; 2017 Oct; 15(1):181. PubMed ID: 28988541 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers. McCarthy JS; Baker M; O'Rourke P; Marquart L; Griffin P; Hooft van Huijsduijnen R; Möhrle JJ J Antimicrob Chemother; 2016 Sep; 71(9):2620-7. PubMed ID: 27272721 [TBL] [Abstract][Full Text] [Related]
11. Azithromycin for treating uncomplicated malaria. van Eijk AM; Terlouw DJ Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286 [TBL] [Abstract][Full Text] [Related]
12. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427 [TBL] [Abstract][Full Text] [Related]
13. Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor. Rottmann M; Jonat B; Gumpp C; Dhingra SK; Giddins MJ; Yin X; Badolo L; Greco B; Fidock DA; Oeuvray C; Spangenberg T Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041711 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria. Guo J; Guiguemde AW; Bentura-Marciano A; Clark J; Haynes RK; Chan WC; Wong HN; Hunt NH; Guy RK; Golenser J Antimicrob Agents Chemother; 2012 Jan; 56(1):163-73. PubMed ID: 22006004 [TBL] [Abstract][Full Text] [Related]
15. Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development. Zaloumis S; Humberstone A; Charman SA; Price RN; Moehrle J; Gamo-Benito J; McCaw J; Jamsen KM; Smith K; Simpson JA Malar J; 2012 Aug; 11():303. PubMed ID: 22931058 [TBL] [Abstract][Full Text] [Related]
16. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial. Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study. Zoleko-Manego R; Okwu DG; Handrich C; Dimessa-Mbadinga LB; Akinosho MA; Ndzebe-Ndoumba WF; Davi SD; Stelzl D; Veletzky L; Kreidenweiss A; Nordmann T; Adegnika AA; Lell B; Kremsner PG; Ramharter M; Mombo-Ngoma G PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010899. PubMed ID: 36315579 [TBL] [Abstract][Full Text] [Related]
18. In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia. Mairet-Khedim M; Nardella F; Khim N; Kim S; Kloeung N; Ke S; Kauy C; Eam R; Khean C; Pellet A; Leboulleux D; Leang R; Ringwald P; Barale JC; Leroy D; Menard D; Witkowski B J Antimicrob Chemother; 2019 Nov; 74(11):3240-3244. PubMed ID: 31518407 [TBL] [Abstract][Full Text] [Related]
19. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. WWARN Gametocyte Study Group BMC Med; 2016 May; 14():79. PubMed ID: 27221542 [TBL] [Abstract][Full Text] [Related]
20. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. McCarthy JS; Rückle T; Djeriou E; Cantalloube C; Ter-Minassian D; Baker M; O'Rourke P; Griffin P; Marquart L; Hooft van Huijsduijnen R; Möhrle JJ Malar J; 2016 Sep; 15(1):469. PubMed ID: 27624471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]